Dr. Pragyan Monalisa Sahoo

About

Pragyan Monalisa Sahoo has a PhD in Health Economics and works in the broader field of Economics of Social Sector. Her primary areas of expertise revolve around Health Financing, Health Insurance, Population Ageing, Health Outcomes, Health Technology Assessment, and the Health Systems of BRICS nations.

Employment

• Symbiosis International University Assistant Professor
  2025 - Present
• Indian Institute of Public Health Gandhinagar Junior Health Economist
  2025 - 2025

Education

• Utkal University PhD
  2021 - 2026
• Utkal University MPhil
  2019 - 2021
• Utkal University MA
  2017 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (40)

• Poverty in Odisha
  2026 DOI: 10.4324/9781003616788-13
  +Save
• The role of health financing system and pluralism in achieving sustainable development goal health outcomes in India: a multilevel analysis
  International Journal for Equity in Health 2026 DOI: 10.1186/s12939-026-02888-x
  +Save
• Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
  Lancet Child and Adolescent Health 2026 DOI: 10.1016/S2352-4642(25)00303-7
  +Save
• Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000-2023: a systematic analysis from the Global Burden of Disease Study 2023
  LANCET CHILD & ADOLESCENT HEALTH 2026
  +Save
• Poverty in Odisha: Past, Present, and Future
  Trajectories of Development Odisha@100 2026 DOI: 10.4324/9781003616788-13
  +Save
• Mapping drivers of life expectancy change in Asia from 1990 to 2023
  Nature 2026 DOI: 10.1038/s41586-026-10739-6
  +Save
• Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study
  NATURE MEDICINE 2026 DOI: 10.1038/S41591-025-04077-9
  +Save
• Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  LANCET ONCOLOGY 2026 DOI: 10.1016/S1470-2045(25)00730-2
  +Save
• Global burden of metabolic dysfunction-associated steatotic liver disease, 1990-2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  LANCET GASTROENTEROLOGY & HEPATOLOGY 2026 DOI: 10.1016/S2468-1253(26)00011-7
  +Save
• Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study
  NATURE MEDICINE 2026 DOI: 10.1038/S41591-025-04137-0
  +Save